McDermott M T, Burman K D, Hofeldt F D, Kidd G S
Am J Med. 1986 Jun;80(6):1245-8. doi: 10.1016/0002-9343(86)90697-2.
Primary hypothyroidism developed in a 57-year-old woman treated for eight years with lithium carbonate for manic-depressive illness, and nine months later she became thyrotoxic. Although autoimmune disease appeared to be responsible, lithium was suspected to play a contributory role in both phases of her illness. This is the first reported case of hyperthyroidism following hypothyroidism in a lithium-treated patient. The 24 reported cases of lithium-associated thyrotoxicosis and the possible mechanisms that may explain this poorly understood phenomenon are also reviewed.
一名57岁女性因躁郁症服用碳酸锂治疗8年后出现原发性甲状腺功能减退,9个月后又出现甲状腺毒症。尽管自身免疫性疾病似乎是病因,但锂被怀疑在其疾病的两个阶段都起到了辅助作用。这是首例有报道的锂治疗患者甲状腺功能减退后继发甲状腺功能亢进的病例。本文还回顾了24例与锂相关的甲状腺毒症报道病例以及可能解释这一尚不清楚现象的潜在机制。